Compare Hudbay Minerals Inc. Ordinary Shares (Canada) (HBM) vs Kymera Therapeutics Inc. Common Stock (KYMR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Hudbay Minerals Inc. Ordinary Shares (Canada) vs Kymera Therapeutics Inc. Common Stock — how do they compare? Hudbay Minerals Inc. Ordinary Shares (Canada) trades at $23.45 (market cap $11.37B), while Kymera Therapeutics Inc. Common Stock trades at $105.11 (market cap $8.87B). The key difference: Hudbay Minerals Inc. Ordinary Shares (Canada) is the larger of the two by market cap, and Hudbay Minerals Inc. Ordinary Shares (Canada) pays a 0.11% dividend while Kymera Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Hudbay Minerals Inc. Ordinary Shares (Canada) for 6 Days and Kymera Therapeutics Inc. Common Stock for 0 Days on average.
| HBM | KYMR | |
|---|---|---|
Market Cap | $11.37B | $8.87B |
Volume | 3,520,423 | 779,107 |
Sector | Basic Materials | Health |
52-Week High | $31.87 | $127.31 |
52-Week Low | $14.58 | $55.80 |
Typical Hold Time | 6 Days | 0 Days |
Enterprise Value | $11.43B | $8.26B |
Dividend Yield | 0.11% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
HudBay Minerals (HBM) trades at $25.68, down 0.31% with bearish technical signals despite solid fundamentals. The company reported strong 2025 results with $2.21B revenue and $568.5M net income, while analyst consensus remains positive with 60% buy ratings. Recent news highlights HBM4 equipment delays and copper/gold reserve expansions at Snow Lake operations.
HBM presents a value opportunity with reasonable valuation (P/E 15.77) and strong profitability (ROE 18.43%), though technical weakness and HBM market dynamics pose near-term risks. The stock's outlook depends on execution of copper growth strategy and resolution of memory sector supply chain concerns.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Hudbay Minerals Inc. Ordinary Shares (Canada)
Hudbay Minerals is a mining company producing copper, gold, zinc, and other metals. Its operations are located in the Americas.
Read more on HBM →About Kymera Therapeutics Inc. Common Stock
Kymera Therapeutics, Inc. is a biopharmaceutical company developing small-molecule medicines based on targeted protein degradation, using its Pegasus platform to direct the body's natural protein-disposal system against disease-causing proteins.
Read more on KYMR →
